TC-DAPK 6 is primarily utilized in biochemical research, particularly in the study of cellular signaling pathways and apoptosis. It serves as a potent and selective inhibitor of death-associated protein kinase (DAPK), enabling researchers to investigate the role of DAPK in various biological processes, including cell death, autophagy, and stress responses. By inhibiting DAPK activity, TC-DAPK 6 helps in understanding the molecular mechanisms underlying diseases such as cancer, neurodegenerative disorders, and ischemic injury. This compound is also valuable in drug discovery efforts aimed at developing therapeutic agents targeting DAPK-related pathways. Its application extends to in vitro and in vivo studies, providing insights into potential strategies for modulating DAPK function in pathological conditions.